Intermountain Healthcare settles drug diversion case for $1M

Salt Lake City-based Intermountain Healthcare has agreed to pay the federal government $1 million to resolve allegations that lax controls allowed a former medical assistant to divert controlled substances for personal use, according to the Department of Justice.

Advertisement

The government alleged a former medical assistant at one of Intermountain’s clinics used a physician’s Drug Enforcement Administration registration number to issue prescriptions for various controlled substances to herself and two family members. She allegedly issued 244 prescriptions of oxycodone and another 151 prescriptions for other controlled substances, including diazepam, phentermine and hydrocodone, without a legitimate medical purpose.

The former medical assistant picked up all of the prescriptions she illegally issued after they were filled by a pharmacy, according to the DOJ.

In addition to the monetary settlement, Intermountain has implemented a corrective action plan to prevent, identify and address future drug diversions.

More articles on legal and regulatory issues:

Statistician: Government used faulty extrapolation in $100M Medicare fraud case
Nurses union sues Care New England to halt hospital closure
11 latest healthcare industry lawsuits, settlements

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.